When an applicant or recruit seeks to apply or enlist, ADHD/ADD diagnosis and medication use disqualifies the individual from being hired for many positions in national defense domestic and abroad.
An advocate can overcome these obstacles with the right knowledge and expertise. Contact Dr. Brown for details and representation.
- Expert Witness in Psychopharmacology Side-effects: Established thriving practice with expertise in healthcare, psychopharmacology, and medical & behavioral effects of the medications with specialty in ADD/ADHD medications, including adverse drug reactions/ adverse drug injury and the lack of authority of the Diagnostic Statistical Manual for diagnosing disorders.
Public Policy Advocacy: Facilitated negotiations in public policy arenas, contributing to improved healthcare outcomes and human rights initiatives through strategic vision and comprehensive policy work in areas like ADHD and long-term medication effects.
The ADHD diagnosis and medication use disqualifies those interested in joining the armed forces for military service. Furthermore, this disqualification also extends to the Federal Bureau of Investigations (FBI), applications are down 84% since 2009, law enforcement, and the US Secret Service. ADHD and the medications has a profound effect on our national security. Numerous agencies providing defense and first responders have seen a dramatic decline in mainly male recruitment from the military, state troopers, and fire departments.
The criteria for diagnosing mental illness stipulated in the Diagnostic and Statistical Manual of Mental Disorders (DSM), particularly Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD) is crippling the nation's national defense. The current classifications have caused epidemics of misdiagnosis and the criteria lacks validity.
Dr. Brown is an accomplished executive with a Doctorate focusing in Public Policy who excels in leadership across diverse sectors. She leads high-stakes negotiations in collaboration with top-tier clientelle such as the FBI, CIA, and DOD.
Over 68%, or seven out of ten Veterans are placed on psychiatric drugs. Twenty-eight percent are prescribed antidepressants, while those prescribed an SSRI are 3.4 times more likely to commit suicide than those who chose “non-treatment”.
Since 911, over 155,000 veterans have died by suicide according to 2001-2022 research for 18–34-year-olds serving their country. The numbers are growing for those dying after taking prescribed psychiatric medication with known side effects of suicidal and homicidal thoughts. There is no deprescribing protocol in this country. The significant growth in the global pharmaceutical market of 1.6 trillion U.S. dollars in revenue was seen in 2023 alone, according to Statista. In fact, a War Cry For Change to End Veteran Overprescribing recently took place on the very steps of the Capitol, with a call for harm reduction for which Dr. Brown was present.
Now, ADHD, the most diagnosed mental illness in children, is the leading disorder disqualifying recruits from serving in our military which has experienced critically low recruitment not seen since the 1970’s. The diagnosis of ADHD and the prescription of stimulants leading to possible psychosis, bipolar, schizophrenia, aggression, addiction, suicidal/homicidal thoughts and brain atrophy disqualifies young recruits. It should be noted the origin of ADHD has never been scientifically proven. Although we do know 1-2% of the population have valid symptoms from minimal brain dysfunction or commonly known as ADHD originating from oxygen deprivation, traumatic brain injury and organic causes. More supportive treatments for those in need with challenges are available for those with valid mental illness. And first and foremost, the undertaking or the revision of the DSM without conflicts of interest that lead to diagnosing normal emotions as disorders is necessary.
Doctorate focused in Public Policy, Georgetown University & McCourt School of Public Policy, Summa Cum Laude
Advocating for the reform of the Diagnostic and Statistical Manual of Mental Disorders (DSM) to protect against bias and misdiagnosis, which emphasizes the need for regulation of the manual to be grounded in scientific reliability and social-ethical justice. Dr. Brown's extensive background is enriched by collaborations with top-tier experts, including the Department of Labor’s lead economist, a White House counterterrorism expert, and a Harvard-trained psychopharmacologist. Her academic interactions provided deep insights into federal budget utilization, Social Security, and healthcare policy, crucial for understanding the pervasive influence of pharmaceutical companies on mental health diagnostics. Dr. Brown advocates for stringent regulatory oversight and ethical standards, as it is a necessity of safeguarding diagnostic integrity to protect public health and national security.